PHATHOM PHARMACEUTICALS INC's ticker is PHAT and the CUSIP is 71722W107. A total of 85 filers reported holding PHATHOM PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.01 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $19,589 | -96.3% | 1,889 | -94.9% | 0.00% | – |
Q2 2023 | $534,480 | +4773.1% | 37,324 | +2329.9% | 0.00% | – |
Q1 2023 | $10,968 | +40.7% | 1,536 | +121.0% | 0.00% | – |
Q4 2022 | $7,798 | -40.0% | 695 | -42.8% | 0.00% | – |
Q3 2022 | $13,000 | +333.3% | 1,215 | +221.4% | 0.00% | – |
Q2 2022 | $3,000 | -57.1% | 378 | -21.7% | 0.00% | – |
Q1 2022 | $7,000 | -99.9% | 483 | -99.7% | 0.00% | – |
Q3 2021 | $4,950,000 | – | 154,200 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Medicxi Ventures Management (Jersey) Ltd | 3,760,869 | $39,000,212 | 12.45% |
Frazier Life Sciences Management, L.P. | 10,109,279 | $104,833,223 | 6.96% |
Decheng Capital Management III (Cayman), LLC | 850,000 | $8,814,500 | 2.94% |
Carlyle Group Inc. | 3,496,808 | $36,191,963 | 1.57% |
Ghost Tree Capital, LLC | 395,000 | $4,096,150 | 1.35% |
Newtyn Management, LLC | 500,000 | $5,185,000 | 1.28% |
Altium Capital Management LP | 220,000 | $2,281,400 | 1.19% |
StepStone Group LP | 422,085 | $4,377,021 | 0.98% |
MPM BioImpact LLC | 347,332 | $3,601,833 | 0.96% |
NEA Management Company, LLC | 1,276,595 | $12,238,290 | 0.94% |